Status:
COMPLETED
Real-life Data of Constitutional Von Willebrand Disease in Western France
Lead Sponsor:
Nantes University Hospital
Conditions:
Von Willebrand Diseases
Eligibility:
All Genders
Brief Summary
The objective of this observational study HOPSCOTcH-WILL II is to provide an accurate and detailed account of current Von Willebrand Disease (VWD) therapeutic management by collecting real-life data o...
Eligibility Criteria
Inclusion
- Constitutional Von Willebrand Disease patient, of any severity, with or without Von Willebrand Factors inhibitors
- Patient included in the research database BERHLINGO
- Patient treated or not by desmopressin or Von Willebrand Factor/FVIII/by-passing agents available on the French market (at baseline)
- Patient who agrees to participate in the HOPSCOTcH-Will II and followed in one of the 5 investigator centers
Exclusion
- \- Patients under guardianship
Key Trial Info
Start Date :
July 7 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
922 Patients enrolled
Trial Details
Trial ID
NCT04887324
Start Date
July 7 2023
End Date
December 31 2024
Last Update
March 30 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, France
2
CHR de Brest
Brest, France
3
CH Le Mans
Le Mans, France
4
CHU de Nantes
Nantes, France